Assessment of free light chains in HCV‐positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|9|2100-2107

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.9, 2015-09, pp. : 2100-2107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients

By  

Oncology, Vol. 80, Iss. 5-6, 2011-08 ,pp. : 366-372

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Intravenous Iron Therapy for HCV-Positive Haemodialysis Patients

By  

Nephron Clin Pract, Vol. 100, Iss. 3, 2005-04 ,pp. : c78-c85

Karger

Access to resources Recommend Favorite

Successful treatment of PR3‐ANCA positive vasculitis with pancreatitis as the first manifestation with rituximab

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 12, 2017-12 ,pp. : 2209-2210

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mixed cryoglobulinaemia: An important but frequently unrecognized and underestimated HCV‐related condition in the real life practice

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 1, 2018-01 ,pp. : 183-183

John Wiley & Sons Inc

Access to resources Recommend Favorite

FREE PAPER HCV TREATMENT O‐24: The German multicenter cohort on direct antiviral agents in HCV‐ and HIV/HCV‐infected patients (GECODAA)

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 14-15

John Wiley & Sons Inc

Access to resources Recommend Favorite